HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) said the U.S. Food and Drug Administration has approved an expanded indication ...
Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth ...
A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...
The pilot project will use artificial intelligence (large language models) to transform complex medical research and ...
Yale epidemiologist Harvey Risch, who has entertained a connection between Covid vaccines and “turbo cancer” and promoted ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
More Iowans are surviving cancer due to advancements in treatments and screenings, but up to a third of survivors experience ...
FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...
Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval making it the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results